| Fund ID | 805-3322422289 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 26% |
| Owned by the adviser or related persons | 98% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Avego Healthcare Capital Fund II, L.P. | Private Equity | $360.9M |
| Avego Healthcare Capital, L.P. | Private Equity | $321.3M |
| Velan Capital Master Fund LP | Hedge | $228.4M |
Avego Bioscience Capital, L.P. reports $84 million in gross assets, among the top 45% of private funds by size.
Avego Bioscience Capital, L.P. is managed by Avego Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.